Targeted antiestrogens to prevent breast cancer

Trends in Endocrinology and Metabolism

Volumn 10, Issue 8, 1999, Pages 312-317

  Jordan, V Craig ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001122847     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00181-2     Document Type: Review

References (41)

1. Lacassagne, A. (1936) Hormonal pathogenesis of adenocarcinoma of the breast Am. J. Cancer 27, 217-225
2. Jensen, E.V. and Jacobson, H.I. (1962) Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res. 18, 387-414
3. Toft, D. and Gorski, J. (1966) A receptor molecule for estrogen, isolation from rat uterus and preliminary characterization. Proc. Natl. Acad. Sci. U. S. A. 55, 1574-1581
4. Toft, D., Shyamala, G. and Gorski, J. (1967) A receptor molecule for estrogens. Studies using a cell free system. Proc. Natl. Acad. Sci. U. S. A. 57, 1740-1743
5. Jensen, E.V., Suzuki, T., Kawashima, T., Stumpf, W.E., Jungblut, P.W. and DeSombre, E.R. (1968) A two-step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. U. S. A. 59, 632-638
6. Gorski, J., Toft, D., Shyamala, G., Smith, D. and Notides, A. (1968) Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog. Horm. Res. 24, 45-72
7. Jensen, E.V., Block, G.E., Smith, S., Kyser, K. and DeSombre, E.R. (1971) Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer lust. Monogr. 34, 55-70
8. Jordan, V.C. (1998) Designer estrogens. Sci. Am. 279, 60-67
9. Lerner, L.J., Holthaus, J.F. and Thompson, C.R. (1958) A non-steroidal estrogen antagonist. 1-(p-2diethylaminoethoxy-phenyl)-1-phenyl-2-p methoxy phenylethanol. Endocrinology 63, 295-318
10. Lemer, L.J. (1981) The first non-steroidal antiestrogen MER 25. In Nonsteroidal Antiestrogens (Sutherland, R.L. and Jordan, V.C., eds), pp 1-16, Academic Press
11. Segal, J.S. and Nelson, W.O. (1958) An orally active compound with antifertility effects in rats. Proc. Soc. Exp. Biol. Med. 98, 431-436
12. Holtkamp, D.E., Greslin, S.C., Root, C.A. and Lerner, L.J. (1960) Gonadotropin inhibiting and antifecundity effects of chloramiphene. Proc. Soc. Exp. Biol. Med 105, 197-201
13. Palopoli, P.P., Feil, V.J., Allen, R.F., Holtkamp, D.E. and Richardson, A., Jr (1967) Substituted aminoalkoxy triarylhaloethylenes. J. Med. Chem. 10, 84-86
14. Ernst, S., Hite, G., Cantrell, J.S., Richardson, A., Jr and Benson, H.D. (1976) Stereochemistry of geometric isomers of clomiphene: a correction of the literature and a re-examination of structure-activity relationships. J. Pharm. Sci. 65, 148-150
15. Huppert, L.C. (1979) Inductions of ovulation with clomiphene citrate. Fertil. Steril. 31, 1-8
16. Emmens, C.W. (1970) Post-coital contraception. Br. Med. Bull. 26, 45-51
17. Lunan, C.B. and Klopper, A. (1975) Antiestrogens: a review. Clin. Endocrinol. 4 551-572
18. Legha, S.S. and Carter, S.K. (1976) Antiestrogens in the treatment of breast cancer. Cancer Treat. Rev. 3, 205-216
19. Harper, M.J.K. and Walpole, A.L. (1967) A new derivative of triphenylethylenc: effect on implantation and mode of action in rats. J. Reprod. Fertil. 13, 101-119
20. Harper, M.J.K. and Walpole, A.L. (1967) Mode of action of ICI 46,474 in preventing implantation in rats. J. Endocrinol. 37, 83-92
21. Williamson, J.G. and Ellis, J.D. (1973) The induction of ovulation by tamoxifen. J. Obstet. Gynaecol. Br. Commonw. 80, 844-847
22. Jordan, V.C. (1988) The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole. Breast Cancer Res. Treat. 11, 197-209
23. Lerner, L.J. and Jordan, V.C. (1990) Development of antiestrogens and their use in breast cancer. Eighth Cain memorial award lecture. Cancer Res. 50, 4177-4189
24. Jordan, V.C. (1993) A current view of tamoxifen for the treatment and prevention of breast cancer. Gaddum memorial lecture. Br. J. Pharmacol. 110, 507-517
25. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351, 1451-1467
26. Jordan, V.C. and Jaspan, T. (1976) Tamoxifen as an antitumor agent: estrogen binding as a predictive test for tumor response. J. Endocrinol. 68, 453-460
27. Jordan, V.C. (1976) Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur. J. Cancer 12, 419-424
28. Jordan, V.C., Dix, C.J. and Allen, K.E. (1979) The effectiveness of long-term treatment in a laboratory model for adjuvant hormone therapy of breast cancer. In Adjuvant Therapy of Cancer (Vol. 2) (Salmon S.E. and Jones, S.E., eds), pp 19-26, Grune and Stratton
29. Beall, P.T., Misra, K.L., Young, R.L., Spjut, H.J., Evan, H.J. and LeBlanc, A. (1985) Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif. Tissue Int. 36, 123-125
30. Black, L.F., Jones, C.D. and Falcone, J.F. (1983) Antagonism of estrogen action with a new benzothiophene-derived antiestrogen. Life Sci. 32, 1031-1036
31. Osborne, C.K., Hobbs, K. and Clark, G.M. (1985) Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45, 584-590
32. Jordan, V.C. and Robinson, S.P. (1987) Species specific pharmacology of antiestrogens: role of metabolism. Fed. Proc. 46, 1870-1874
33. Gottardis, M.M. and Jordan, V.C. (1987) The antitumor actions of keoxifene (raloxifene) and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res. 47, 4020-4024
34. Jordan, V.C., Phelps, E. and Lindgren, J.U. (1987) Effects of antiestrogeus on bone in castrated and intact female rats. Breast Cancer Res. Treat. 10, 31-35
35. Love, R.R. et al. (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. New Engl. J. Med. 326, 852-856
36. Delmas, P.D. et al. (1997) Effect of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. New Engl. J. Med. 337, 1641-1647
37. Gottardis, M.M., Robinson, S.P., Satyaswaroop, P.G. and Jordan, V.C. (1988) Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res. 48, 812-815
38. Jordan, V.C. et al. (1998) Incident breast cancers are reduced by raloxifene: integrated data from multicenter, double-bind randomized trials in approx. 12,000 postmenopausal women. Proc. Am. Soc. Clin. Oncol. 17, 466 (abstr)
39. MacGregor, J.I. and. Jordan, V.C. (1998) Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50, 151-196
40. Jordan, V.C. and Morrow, M. (1999) Tamoxifen, raloxifene and the prevention of breast cancer. Endocr. Rev. 20, 253-278
41. Buzdar, A.U. et al (1988) Phase II evaluation of LY156758 in metastatic breast cancer. Oncology 45, 344-345